Semnur Pharmaceuticals

Semnur Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing non-opioid pain-management therapies. Its lead program, SP-102 (SEMDEXA), is a novel, non-opioid, preservative-free and particulate-free injectable corticosteroid gel formulation intended to treat moderate-to-severe chronic radicular pain (sciatica). Semnur is a subsidiary of Scilex Holding Company and is headquartered in the San Francisco Bay Area, California. As a pharmaceutical R&D company it publishes a corporate website, investor presentation, and scientific publications, but exposes no public developer API, documentation, or SDK surface.

Semnur Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biopharmaceutical, Healthcare, and Pain Management.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyPharmaceuticalsBiopharmaceuticalHealthcarePain ManagementNon-OpioidClinical StageLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/semnur-pharmaceuticals: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website

Website

Other 2

Properties that don't map to a standard resource type

Publications

Publications

Presentation

Presentation

Source (apis.yml)

aid: semnur-pharmaceuticals
name: Semnur Pharmaceuticals
description: Semnur Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing non-opioid pain-management
  therapies. Its lead program, SP-102 (SEMDEXA), is a novel, non-opioid, preservative-free and particulate-free injectable
  corticosteroid gel formulation intended to treat moderate-to-severe chronic radicular pain (sciatica). Semnur is a subsidiary
  of Scilex Holding Company and is headquartered in the San Francisco Bay Area, California. As a pharmaceutical R&D company
  it publishes a corporate website, investor presentation, and scientific publications, but exposes no public developer API,
  documentation, or SDK surface.
url: https://raw.githubusercontent.com/api-evangelist/semnur-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-parent: Scilex Holding Company
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Pharmaceuticals
- Biopharmaceutical
- Healthcare
- Pain Management
- Non-Opioid
- Clinical Stage
- Life Sciences
image: https://semnurpharma.com
apis: []
common:
- type: Website
  url: https://semnurpharma.com
- type: Publications
  url: https://semnurpharma.com/publications/
- type: Presentation
  url: https://semnurpharma.com/presentation/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 0
  pass: local-v1